A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder
Status:
Completed
Trial end date:
1998-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the time to relapse in patients with schizophrenia and
schizoaffective disorders receiving risperidone or haloperidol (antipsychotic medications)
for at least 1 year.